Early in vitro priming of distinct T(h) cell subsets determines polarized growth of visceralizing Leishmania in macrophages

International Immunology

Volumn 12, Issue 9, 2000, Pages 1227-1233

  Gomes, N A ^a   Barreto de Souza, V ^a   DosReis, G A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cytokines; Differentiation; IL 10; Leishmania; T(h)1 T(h)2; Visceral leishmaniasis

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BLAST TRANSFORMATION; CELL CULTURE; CONTROLLED STUDY; FEMALE; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION CONTROL; LEISHMANIA CHAGASI; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE DEVELOPMENT; PARASITOSIS; PRIORITY JOURNAL; PROMASTIGOTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VISCERAL LEISHMANIASIS;

EID: 0033842066     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.9.1227     Document Type: Article

References (27)

1. + lymphocytes in vivo during healing and progressive murine leishmaniasis
2. Differential production of T(h)1- and T(h)2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis
3. Local suppression of IFN-γ in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi
4. Destruction of follicular dendritic cells during chronic visceral leishmaniasis
5. + T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7-1/CTLA-4 molecular pathway
6. Interleukin 12 is effective treatment for an established systemic intracellular infection: Experimental visceral leishmaniasis
7. Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis
8. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani
9. Immunobiological studies on experimental visceral leishmaniasis. V. The I-A (Bm12) mutation specifies resistance to infection
10. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani
11. Genetic control of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to L. donovani infection
12. Natural resistance to infection with intracellular parasites: Molecular genetics identifies Nramp 1 as the Bcg/Ity/Lsh locus
13. + T cell-intrinsic mechanism
14. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice
15. Genetic control of natural resistance to Leishmania donovani
16. +, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice
17. The role of complement in the acute inflammatory process in the skin and in host-parasite interaction in hamsters inoculated with Leishmania (Leishmania) chagasi
18. A simple method for quantifying Leishmania in tissues of infected animals
19. Transforming growth factor-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar
20. An in vitro model for infection with Leishmania major that mimics the immune response in mice
21. Interleukin 10 production correlates with pathology in human Leishmania donovani infections
22. In vivo cytokine profiles in patients with kalaazar
23. Experimental Leishmania major infection in mice: Role of IL-10
24. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production
25. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani
26. Expression of the natural resistance gene Lsh in resident liver macrophages
27. Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: Influence on antigen processing and presentation